The partnership is anticipated to meet the increasing demand for innovative injection solutions. Credit: Triggermouse from Pixabay.

Medical device company Sharps Technology is set to enhance its global distribution and sales network for drug delivery systems through new North American third-party logistics (3PL) partnerships and a strategic alliance with Roncadelle Operations.

This collaboration aims to leverage the combined strengths of both companies to market and distribute unique drug delivery solutions worldwide, tapping into a growing logistics network.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The partnership between Sharps Technology and Roncadelle Operations is expected to unite their complementary product portfolios, extending Sharps’s market presence from the US to Europe, the Middle East, Africa, and the Asia-Pacific region, and introducing the latter’s products to the healthcare markets in North and South America.

This move is anticipated to meet the increasing demand for innovative injection solutions across various therapeutic areas.

The alliance is also set to become a significant force in the syringe market by advancing technologies such as prefilled syringes, needle guard systems, auto-injectors, and injector pen devices.

Sharps Technology’s product lines, Securegard and Sologard, are at the forefront of low-waste and ultra-low-waste syringe technologies.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The company, with a manufacturing facility in Hungary, is exploring expansion opportunities in the US.

Sharps CEO Robert Hayes said: “It is exciting to see how well our companies complement each other and how we can leverage our combined relationships, expertise, and resources to build out our distribution network, enhance syringe safety around the world, and introduce novel drug delivery solutions to the healthcare industry.

“As we work through the network expansion and details of our collaboration, we can see that this is great timing and a perfect fit for both Sharps and Roncadelle.”